Regulation
FDA clears Abbott’s CardioMEMS HF system updates
Abbott received FDA clearance for software updates to its CardioMEMS HF System, a remote monitoring platform for heart failure patients. The updates introduce new digital features enabling patients to track cardiac data on mobile devices, expanding the system's remote monitoring and data management capabilities.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network